Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
3 Mar 2008
Changes in UCB's Executive Committee
Read More
29 Feb 2008
UCB: Full Year 2007 Financial Results
Read More
19 Feb 2008
FDA Approves XYZAL® (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
Read More
6 Feb 2008
FDA Agrees to Review Cimzia® File for the Treatment of Rheumatoid Arthritis
Read More
16 Jan 2008
Keppra XR(TM) Extended- Release Tablets Filed with the FDA
Read More
14 Dec 2007
UCB on Track
Read More
14 Dec 2007
Changes in UCB's Board of Directors
Read More
13 Dec 2007
Neupro® Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
Read More
13 Dec 2007
Neupro® Filed with the FDA for the Treatment of Restless Legs Syndrome
Read More
11 Dec 2007
New Phase III Trial Shows Positive Outcome of lacosamide in Patients with Diabetic Neuropathic Pain
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
89
Page
90
Page
91
Page
92
Current page
93
Page
94
Page
95
Page
96
Page
97
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss